In the case of familial ALS, mutations in the SOD1 gene alter its antioxidant capacity, leading to ROS accumulation that inactivates axonal transport, induces axonal degeneration, and causes SOD1 to bind to Bcl-2, inhibiting Bcl-2’s anti-apoptotic activity. Here, BCL2 is linked to amyotrophic lateral sclerosis.